Hassan Salmanroghani et. al., in their research paper titled: “Efficacy and tolerability of two quadruple regimens: bismuth, omeprazole, metronidazole with amoxicillin or tetracycline as first-line treatment for eradication of Helicobacter pylori in patients with duodenal ulcer: a randomized clinical trial”, (2018) evaluates the efficacy of two quadruple treatment regimens for eradication duodenal cancers in patients infected with Helicobacter pylori with bismuth, omeprazole, metronidazole with amoxicillin or tetracyline and asserts that an amoxicillin quadruple regimen method is the most efficient metho for eradication of H. pylori. The conclusion of an amoxicillin treatment was come upon through experimental trial and result of amoxicillin yielding more efficient results than that of a quadruple regimen containing tetracycline. The purpose of this clinical trial was to determine the efficacy of multiple quadruple regimens compared amongst each other for eradication of Helicobacter pylori in those with duodenal cancers for future treatment protocol. Salmanroghani et. al., establishes a scholarly relationship with peers in microbiological and cell & molecular sciences fields of expertise.
Reference:
- Salmanroghani, H., Mirvakili, M., Baghbanian, M., Salmanroghani, R., Sanati, G., & Yazdian, P. (2018). Efficacy and tolerability of two quadruple regimens: bismuth, omeprazole, metronidazole with amoxicillin or tetracycline as first-line treatment for eradication of Helicobacter pylori in patients with duodenal ulcer: a randomized clinical trial. Plos One, 13. doi:10.1371/journal.pone.0197096
